PeerVoice Oncology & Haematology Audio
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 71:10:26
- Mais informações
Informações:
Sinopse
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Episódios
-
![Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat]()
Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat
01/11/2022 Duração: 21minMohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat
-
![Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022]()
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
27/10/2022 Duração: 23minNoemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
-
![Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals]()
Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals
19/10/2022 Duração: 18minRana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals
-
![Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC]()
Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
04/10/2022 Duração: 01h20minContemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
-
![Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice]()
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice
03/10/2022 Duração: 24minExpert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice
-
![Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC]()
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
29/09/2022 Duração: 27minRight Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
-
![Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit]()
Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit
29/09/2022 Duração: 18minManaging Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit
-
![Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC]()
Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC
20/09/2022 Duração: 24minHot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC
-
![Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care]()
Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care
07/09/2022 Duração: 55minReassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care
-
![Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions]()
Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions
07/09/2022 Duração: 20minPersonalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions
-
![Question Time: Applying New Therapies for the Management of mTNBC]()
Question Time: Applying New Therapies for the Management of mTNBC
29/08/2022 Duração: 38minQuestion Time: Applying New Therapies for the Management of mTNBC
-
![New Biomarkers, New Targets in Advanced NSCLC]()
New Biomarkers, New Targets in Advanced NSCLC
17/08/2022 Duração: 20minNew Biomarkers, New Targets in Advanced NSCLC
-
![Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias]()
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
01/08/2022 Duração: 18minAddressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
-
![IAP Antagonists in Oncology: What Do We Know?]()
IAP Antagonists in Oncology: What Do We Know?
25/07/2022 Duração: 23minIAP Antagonists in Oncology: What Do We Know?
-
![Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC]()
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
11/07/2022 Duração: 37minPractical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
-
![Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022]()
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
30/06/2022 Duração: 19minInsights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
-
![Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors]()
Managing the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors
26/05/2022 Duração: 21minManaging the Nuances of Paroxysmal Nocturnal Haemoglobinuria: Practical Strategies for Patients Receiving Complement Inhibitors
-
![Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID]()
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID
18/05/2022 Duração: 21minManaging Thrombosis in Cancer: A Double Debacle and Then Add COVID
-
![‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B]()
‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B
16/05/2022 Duração: 18min‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B
-
![Personalising Management of Advanced RCC: How I Treat]()
Personalising Management of Advanced RCC: How I Treat
16/05/2022 Duração: 09minPersonalising Management of Advanced RCC: How I Treat
